Increased tone of skeletal muscles due to organic neurological disorders (e.g. injury of the pyramidal tract, multiple sclerosis, myelopathy, encephalomyelitis etc.), muscular hypertension, muscular spasm, muscular contracture, rigidity, spinal automatism and discopathy. Obliterative vascular diseases (obliterative arteriosclerosis, diabetic angiopathy, obliterative thromboangitis, Raynaud\'s disease, diffuse scleroderma) and disorders due to injured innervation of the vessels (acrocyanosis, intermittent angioneurotic dysbasia). In individual cases post-thrombotic venous and lymphatic circulation disorders, crural ulcer
sodium and calcium channels blocker.
Tolperisone Hydrochloride is a centrally acting muscle relaxant. It effectively reduces muscular hypertonicity, improves peripheral blood flow by vasodilatation and reduces pain. Lidocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses, thereby effecting local anesthetic action.
Adult: 50-150 mg three times daily according to the individual requirement and tolerance of the patient. Children (from 3 months to 6 years): 5-10 mg/kg/day in three divided doses. Children (from 6 to 14 years): 2-4 mg/kg/day in three divided doses.
Hypersensitivity to any component of the product Myasthenia gravis. In case of children, the prescribed dose and duration of treatment should closely be observed.
Muscular weakness, headache, hypotension, nausea, vomiting, abdominal discomfort.
Tolperisone hydrochloride should be used in pregnancy according to physician's advice. Tolperisone hydrochloride should not be used during breast feeding
In the event of over dosage, supportive therapy may be substituted.
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
.png&w=384&q=75)